InteRNA presents data on drug formulation and mode of action of lead oncology development candidate INT-1B3 at the 15th annual OTS meeting

October 31, 2019

InteRNA presents data on drug formulation and mode of action of lead oncology development candidate INT-1B3 at the 15th annual OTS meeting

InteRNA presents data on drug formulation and mode of action of lead oncology development candidate INT-1B3 at the 15th annual OTS meeting.

Please click here to read the InteRNA Poster#138 showing the data.

Home > News > InteRNA presents data on drug formulation and m...

© 2021 Aglaia Oncology Funds | Privacy | Sitemap
Aglaia Oncology Funds